Cargando…
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?
Rheumatoid arthritis (RA) is a chronic inflammatory disease of the synovial joints, with progressive destruction of cartilage and bone. Anti-tumour necrosis factor-α therapies (e.g. soluble tumour necrosis factor receptors) ameliorate disease in 60–70% of patients with RA. However, the need for repe...
Autores principales: | van de Loo, Fons AJ, Smeets, Ruben L, van den Berg, Wim B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC546285/ https://www.ncbi.nlm.nih.gov/pubmed/15380032 http://dx.doi.org/10.1186/ar1214 |
Ejemplares similares
-
Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?
por: van de Loo, Fons A, et al.
Publicado: (2009) -
Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?
por: van de Loo, Fons AJ
Publicado: (2011) -
Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium
por: Abdollahi-Roodsaz, Shahla, et al.
Publicado: (2011) -
Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models
por: Waterborg, Claire E. J., et al.
Publicado: (2018) -
Lessons from animal models of arthritis over the past decade
por: Berg, Wim B van den
Publicado: (2009)